David Oakes

发表

DISCUSSION OF PAPER BY WEI AND GLIDDEN

R. J. Spiegel, Jerald F. Lawless, Richard J. Cook, 1997 .

Analyzing Data from Premeasure/Postmeasure Designs

David Oakes, Sharon Anderson, Ariane Auquier, 2008 .

Frailty Models For Multiple Event Times

David Oakes, D. Oakes, 1992 .

Statistical Methods for Comparative Studies Techniques for Bias Reduction

Walter Vandaele, I. Sutherland, Walter W. Hauck, 1980 .

Semi-Markov representations of some stochastic point processes

David Oakes, David Oakes, 1972 .

Self-Calibrating Priors Do Not Exist

David Oakes, D. Oakes, 1985 .

Bivariate Markov Processes of Intervals

David Oakes, 1976, Inf. Control..

Are Ambient Ultrafine, Accumulation Mode, and Fine Particles Associated with Adverse Cardiac Responses in Patients Undergoing Cardiac Rehabilitation?

Yungang Wang, Wojciech Zareba, David Oakes, 2012, Environmental health perspectives.

Prognostic significance of nonfatal myocardial reinfarction

David Oakes, Jesaia Benhorin, Arthur J. Moss, 1990 .

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.

David Oakes, John P Seibyl, D. Jennings, 2004, Archives of neurology.

Ambient and controlled exposures to particulate air pollution and acute changes in heart rate variability and repolarization

Wojciech Zareba, Philip K. Hopke, Alexandra Schneider, 2019, Scientific Reports.

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa

Anthony E. Lang, Stanley Fahn, David Oakes, 1996 .

Impaired olfaction and other prodromal features in the Parkinson At‐Risk Syndrome study

Danna Jennings, David Oakes, Andrew Siderowf, 2012, Movement disorders : official journal of the Movement Disorder Society.

The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α‐tocopherol

David Oakes, Peter A. LeWitt, D. Oakes, 1997 .

Head injury and Parkinson's disease risk in twins

David Oakes, C. Tanner, S. Goldman, 2006, Annals of neurology.

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Joel S Perlmutter, David Oakes, Karl Kieburtz, 2002, Archives of neurology.

Use of Compliance Measures in an Analysis of the Effect of Diltiazem on Mortality and Reinfarction After Myocardial Infarction

Terry M. Therneau, Joseph L. Fleiss, David Oakes, 1993 .

Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments

Anthony E. Lang, David Oakes, Bernard Ravina, 2013, Movement disorders : official journal of the Movement Disorder Society.

Effect of deprenyl on the progression of disability in early Parkinson's disease.

Anthony E. Lang, Stanley Fahn, Joseph H. Friedman, 1989, The New England journal of medicine.